Therapeutic Plasma Exchange with Continuous Renal Replacement Therapy for Pediatric Acute Liver Failure: A Case Series from Thailand
Open Access
- 7 July 2021
- journal article
- research article
- Published by Jaypee Brothers Medical Publishing in Indian Journal of Critical Care Medicine
- Vol. 25 (7) , 812-816
Abstract
Pediatric acute liver failure (PALF) is a life-threatening condition. Extracorporeal support has been applied for toxic metabolite clearance and serves as a bridging therapy to liver transplantation (LT) or to the regeneration of the liver, but evidence for treatment approaches is still lacking in the pediatric population. We aim to report our experience on therapeutic plasma exchange with high-volume continuous renal replacement therapy (TPE + HV-CRRT) as a promising supportive treatment for PALF. A total of eight PALF cases aged 9 months to 14 years, weighing 10–50 kg., who were admitted to PICU King Chulalongkorn Memorial Hospital, Thailand and treated with TPE + HV-CRRT from January 2016 to September 2019 were reviewed. Patient demographic data, indications, technical aspects, and clinical outcomes were recorded. All patients who underwent TPE + HV-CRRT showed clinical improvement regarding serum bilirubin levels and coagulation studies after the therapy. Complications from the therapy were hemodynamic instability, symptomatic fluid overload, and bleeding from catheter sites. Among these, 6 (75%) patients survived with 4 (50%) successful LTs and 2 (25%) spontaneous recovery. Two children (25%) died while on the transplantation list. TPE + HV-CRRT can be used safely as a bridging therapy in children with PALF. As opposed to the adult population, higher volume of TPE or higher blood flow rate in pediatric patients might associate with hemodynamic instability during the procedure. Trepatchayakorn S, Chaijitraruch N, Chongsrisawat V, Chanakul A, Kongkiattikul L, Samransamruajkit R. Therapeutic Plasma Exchange with Continuous Renal Replacement Therapy for Pediatric Acute Liver Failure: A Case Series from Thailand. Indian J Crit Care Med 2021;25(7):812–816.Keywords
This publication has 13 references indexed in Scilit:
- Part of plasmapheresis with plasma filtration adsorption combined with continuous hemodiafiltration in the treatment of severe acute liver failureExperimental and Therapeutic Medicine, 2016
- Guidelines on the Use of Therapeutic Apheresis in Clinical Practice–Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special IssueJournal of Clinical Apheresis, 2016
- Fulminant Wilson’s Disease Managed with Plasmapheresis as a Bridge to Liver TransplantCase Reports in Medicine, 2014
- Efficacy of liver assisting in patients with hepatic encephalopathy with special focus on plasma exchangeMetabolic Brain Disease, 2013
- High-volume Hemofiltration in the Intensive Care UnitAnesthesiology, 2012
- Efficacy of high-flow dialysate continuous hemodiafiltration in the treatment of fulminant hepatic failureTransfusion and Apheresis Science, 2009
- Intensive care of patients with acute liver failure: Recommendations of the U.S. Acute Liver Failure Study GroupCritical Care Medicine, 2007
- Acute liver failure in children: The first 348 patients in the pediatric acute liver failure study groupThe Journal of Pediatrics, 2006
- Preoperative preparation of patients with advanced liver diseaseCritical Care Medicine, 2004
- Combined twice-daily plasma exchange and continuous veno-venous hemodiafiltration for bridging severe acute liver failureTransplantation Proceedings, 2003